Argan (AGX) Results And Dividend Put Its Valuation Narrative Back In Focus

Dividend announcement and quarterly results put Argan in focus

Argan (AGX) has drawn fresh attention after reporting quarterly revenue and net income figures alongside a new US$0.70 cash dividend with an ex-date of October 22, 2026.

The update links recent share price moves to concrete developments in the power generation construction business, providing investors with new data on operations, capital allocation, and the project backlog that supports future work.

Recent trading has been choppy for Argan, with the share price falling 3.6% on the day to US$404.39 after a 7% gain over the past week. Over the past 90 days, the share price return is down 41.2%, while the 1 year total shareholder return sits at 44.3% and the 3 year total shareholder return is close to 8x. This suggests long term holders have seen strong gains even as near term momentum has cooled around the dividend and earnings headlines.

Capitalize on the renewed interest in Argan by sizing it up against a hand-picked 29 high quality undervalued stocks that also pair strong balance sheets with meaningful cash generation.

Argan’s share price has moved sharply, while analyst estimates and some intrinsic value models indicate a much higher level. Is the recent pullback closing the valuation gap or widening it?

Most Popular Narrative: 29% Undervalued

Argan’s most followed valuation storyline points to a fair value of $570.50 versus the last close at $404.39, which frames the recent pullback as a gap between price and that narrative anchor rather than a clean reset.

The aging North American power infrastructure and rising electricity demand, driven by widespread electrification and the proliferation of AI data centers, are resulting in record project backlog and robust pipeline visibility for Argan. This is described as a key factor behind expectations for sustained top-line revenue growth over several years.

See why 127 investors see Argan as 29% undervalued.

Result: Fair Value of $570.50 (UNDERVALUED)

Still, the Argan story can change quickly if crew capacity hits a hard ceiling or if large gas power awards slow more than the bullish narrative assumes.

Find out about the key risks to this Argan narrative.

Another View: Argan Through The Cash Flow Lens

On earnings and price targets, Argan looks undervalued against that US$570.50 fair value anchor. The SWS DCF model tells a very different story and places future cash flows closer to US$220.44 per share, which implies the stock is expensive. Which narrative do you think fits your own assumptions about growth and risk?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Argan for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 29 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals around Argan do not have to leave you stuck on the fence. Move quickly, review the numbers, and weigh both sides by checking the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Argan?

Do not stop with one stock. Use the Simply Wall Street Screener to pressure test your thesis against fresh ideas that might fit your goals even better.

• Target dependable income streams by reviewing companies in the 8 dividend fortresses that focus on higher yields backed by current fundamentals.
• Hunt for mispriced opportunities and compare Argan against a broader 29 high quality undervalued stocks that combine healthy finances with appealing valuations.
• Prioritize capital preservation by scanning a 31 resilient stocks with low risk scores designed to spotlight businesses with more resilient risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com